During the past decade, Jonathan Lax Center at Philadelphia FIGHT conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jonathan Lax Center at Philadelphia FIGHT" #1 collaborator was "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials as a collaborator, "National Institutes of Health (NIH)" with 1 trials as a collaborator, "Philadelphia Fight" with 1 trials as a collaborator and "Rockefeller University" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Jonathan Lax Center at Philadelphia FIGHT" are "HIV" (2 trials), "HIV/AIDS" (2 trials) and "HIV-1 Infection" (1 trials). Many other conditions were trialed in "Jonathan Lax Center at Philadelphia FIGHT" in a lesser frequency.

Most popular intervention types in "Jonathan Lax Center at Philadelphia FIGHT" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "3BNC117 + 10-1074" (1 trials), "Peg-IFN-α2b" (1 trials) and "Pegylated Interferon alpha 2b (peg-IFN-α2b)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Jonathan Lax Center at Philadelphia FIGHT" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Jonathan Lax Center at Philadelphia FIGHT". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Jonathan Lax Center at Philadelphia FIGHT, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Jonathan Lax Center at Philadelphia FIGHT, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".